Clinical and Histopathologic Features of Fluoroquinolone-Induced Liver Injury
- 30 June 2011
- journal article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 9 (6), 517-523.e3
- https://doi.org/10.1016/j.cgh.2011.02.019
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment methodHepatology, 2010
- Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver FailureGastroenterology, 2009
- Safety Profile of the Respiratory Fluoroquinolone MoxifloxacinDrug Safety, 2009
- Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United StatesGastroenterology, 2008
- Drug-Induced Liver InjuryDrug Safety, 2007
- The safety profile of the fluoroquinolonesClinical Therapeutics, 2000
- Trovafloxacin-Induced Acute HepatitisClinical Infectious Diseases, 2000
- Cholestatic hepatitis related to quinolones: a report of two casesJournal of Hepatology, 1995
- Norfloxacin-induced hepatotoxicityJournal of Hepatology, 1990
- Criteria of drug-induced liver disorders: Report of an International Consensus MeetingJournal of Hepatology, 1990